Without a Ribbon
  • About
    • Events
    • Get In Touch
  • Rare Cancer Resources
  • Shop
  • How You Can Help
  • Meet Warriors
  • News
  • Login
  • Register

Select Page

HELP

LEARN

EVENTS

EWSR1 SMAD3 Rearranged Fibroblastic Tumour

Become part of our growing rare cancer community.
Join our Facebook support group

Join Now

Posted by fatima.shakeel@opmc.co | Apr 28, 2026

What is a EWSR1 SMAD3 Rearranged Fibroblastic Tumour?

EWSR1 SMAD3 Rearranged Fibroblastic Tumour is a very rare and recently discovered type of soft tissue tumour. It develops from fibroblasts which are normal cells in the body that help form connective tissue such as skin, tendons, and supporting structures. In this condition a genetic change happens where two genes, called EWSR1 and SMAD3, join together abnormally. This change disturbs normal cell growth and leads to tumour formation.

This tumour is generally considered low-grade, which means it grows slowly and is less aggressive compared to many other cancers. It usually stays localised and does not spread to distant parts of the body.

Incidence

This tumour is extremely rare, and only a small number of cases have been reported worldwide. It can occur in both children and adults, but it is more commonly seen in young to middle-aged individuals.

Symptoms

Most patients notice a small lump under the skin. This lump is usually painless and grows slowly over time. It is most commonly found in the hands, feet or other parts of the limbs. The skin over the lump usually looks normal. Because it grows slowly and does not cause pain, many people ignore it in the early stages.

Diagnosis

First of all, imaging tests such as ultrasound or MRI are performed to evaluate the lump. However, the final diagnosis requires a biopsy where a small sample of the tissue is taken and examined under a microscope. Special genetic testing is very important as it confirms the presence of the EWSR1-SMAD3 gene rearrangement, which is the key feature of this tumour.

Treatment

The main treatment is surgical removal of the tumour. Since it is usually low-grade, surgery alone is often enough. There is usually no need for chemotherapy or radiation therapy unless the tumour behaves unusually.

Prognosis

The prognosis is very good. Most patients recover completely after surgery. The risk of spread is extremely low. However, if the tumour is not fully removed it may come back in the same area, so regular follow-up is important.


You can help us with your donation:

Without a Ribbon is a charity that works hard to aid those who suffer from rare cancers. You can help our cause in a variety of ways:

Donations — Without a Ribbon is grateful when we receive every donation. Giving to Without a Ribbon helps us to provide ongoing support, organise the annual gathering and subsidise the costs of our Warriors attending these conferences.
Sponsorship — If you wish to sponsor our charity, please contact us using this form.
Volunteering — We are always looking for volunteers to help with different aspects of running our charity. So, if you are looking for volunteer work, please feel free to contact us.

Share:

PreviousOur New Resource Page for DICER1 Associated Sarcoma
NextOur New Resource Page for EWSR1 SMAD3 Rearranged Fibroblastic Tumour

If you need any help or advice just

Get In Touch

© Without a Ribbon 2019. All rights reserved.Powered by WEB 105 Creative

Stay up to date.

Sign up to our newsletter